MediPharm Labs Corp. (TSX:LABS)

Market Cap	33.99M -3.7%
Revenue (ttm)	43.28M +0.7%
Net Income	-8.75M
EPS	-0.02
Shares Out	424.86M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,024
Average Volume	521,374
Open	0.0800
Previous Close	0.0800
Day's Range	0.0800 - 0.0800
52-Week Range	0.0600 - 0.1000
Beta	0.96
RSI	50.65
Earnings Date	May 13, 2026

About MediPharm Labs

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis p...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2015
• Employees: 127
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: LABS

Financial Performance

In 2025, MediPharm Labs's revenue was 45.12 million, an increase of 7.54% compared to the previous year's 41.96 million. Losses were -8.27 million, -22.69% less than in 2024.